CN103623242A

CN103623242A - Medicament for treating hyperlipemia on inspection

Info

Publication number: CN103623242A
Application number: CN201310615920.XA
Authority: CN
Inventors: 郭伟
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-11-27
Filing date: 2013-11-27
Publication date: 2014-03-12
Anticipated expiration: 2033-11-27
Also published as: CN103623242B

Abstract

The invention relates to a medicament for treating hyperlipemia on inspection. The medicament is prepared from the following bulk drugs in parts by weight: 6 parts of atractylodes macrocephala koidz, 8 parts of rhodobryum giganteum, 5 parts of herba lepisori, 3 parts of radix codonopsis, 5 parts of common pistache fruit, 6 parts of poria, 3 parts of costusroot, 2 parts of uncinata spikemoss herb, 3 parts of rotala rotundifolia, 9 parts of medlar, 2 parts of polypodiodes amoena, 2 parts of jenkine dendrobium, 5 parts of cornus officinalis, 2 parts of smilax riparia, and 2 parts of common adenostema herb. Nature medicines are used in the medicament for treating hyperlipemia on inspection, so that the medicament has the advantages of quick response, good curative effect and no toxic or side effect.

Description

A kind of medicament of checking treatment hyperlipemia

Technical field

The present invention relates to field of medicaments, specifically, relate to a kind of medicament of checking treatment hyperlipemia.

Background technology

Hyperlipemia is atherosclerotic material base and principal element, is the risk factor of the diseases such as coronary heart disease, hypertension.Studying clinically the method for the treatment of hyperlipemia in check effectively always.

Summary of the invention

The object of this invention is to provide a kind of medicament of checking treatment hyperlipemia.

In order to realize object of the present invention, the invention provides a kind of medicament of checking treatment hyperlipemia, it is to be made by weight by following bulk drugs: 2 parts of 6 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts of Rhizoma Arisaematis, 5 parts of Herba Lepisori Thunbergiani, 3 parts of Radix Codonopsis, 5 parts of Fructus Pistaciae Veraies, 6 parts, Poria, 3 parts of the Radix Aucklandiae, 2 parts of CUIYUNCAO, 3 parts of water Semen Sojae Preparatums, 9 parts of Fructus Lycii, 2 parts of native broken benefits, 2 parts of Dendrobium jenkinsii Wall ex Lindl．, 5 parts of Fructus Corni, 2 parts of Radix et Rhizoma Smilacis Ripariae and Herba Adenostemmatiss.

Preferably, described medicament is tablet, dispersible tablet, instant, powder or granule.

In compositions of the present invention, the Rhizoma Atractylodis Macrocephalae, Rhizoma Arisaematis, Herba Lepisori Thunbergiani are monarch drug; Radix Codonopsis, Fructus Pistaciae Verae, Poria, the Radix Aucklandiae are ministerial drug; CUIYUNCAO, water Semen Sojae Preparatum, Fructus Lycii, native broken benefit are adjuvant drug; Dendrobium jenkinsii Wall ex Lindl．, Fructus Corni, Radix et Rhizoma Smilacis Ripariae and Herba Adenostemmatis be for making medicine, various composition synergism, thereby performance optimum efficiency.

In check of the present invention, treat in the medicament of hyperlipemia and use natural drug, so it has advantages of instant effect, good effect, has no side effect.

Accompanying drawing explanation

With reference to < < Chinese medicine voluminous dictionary > > second edition, being described as follows of some crude drug that use in the present invention:

Fig. 1 is the explanation of Rhizoma Arisaematis;

Fig. 2 is the explanation of Herba Lepisori Thunbergiani;

Fig. 3 is the explanation of Fructus Pistaciae Verae;

Fig. 4 is the explanation of CUIYUNCAO;

Fig. 5 is the explanation of water Semen Sojae Preparatum;

Fig. 6 is the explanation of native broken benefit;

Fig. 7 is the explanation of Dendrobium jenkinsii Wall ex Lindl．;

Fig. 8 is the explanation of Radix et Rhizoma Smilacis Ripariae;

Fig. 9 is the explanation of Herba Adenostemmatis.

The specific embodiment

Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.

The preparation of embodiment 1 powder of the present invention

Get 20 grams of 60 grams of the Rhizoma Atractylodis Macrocephalaes, 80 grams of Rhizoma Arisaematis, 50 grams of Herba Lepisori Thunbergiani, 30 grams of Radix Codonopsis, 50 grams of Fructus Pistaciae Veraies, 60 grams, Poria, 30 grams of the Radix Aucklandiae, 20 grams of CUIYUNCAO, 30 grams of water Semen Sojae Preparatums, 90 grams of Fructus Lycii, 20 grams of native broken benefits, 20 grams of Dendrobium jenkinsii Wall ex Lindl．, 50 grams of Fructus Corni, 20 grams of Radix et Rhizoma Smilacis Ripariae and Herba Adenostemmatiss, pulverize, cross 100 mesh sieves, then add 350 grams of sucrose, mix, uniform distribution packs in 100 bags and get final product.

Experimental example

Diagnostic criteria

With reference to the guideline of clinical investigations > > of the upper treatment of < < new Chinese medicine check hyperlipemia (Zheng Xiao cornel. study of tcm new drug clinical guidance principle [S]. Beijing: Chinese Medicine science and technology publishing house, 2002:85) and national dyslipidemia in 2007 visit and control < < Blood Lipid Abnormality in Chinese Adults guideline of prevention and treatment > > and u.s. national cholesterol education program (NCEP) the adult treatment expert group (ATP) that countermeasure group writes and (ATP-III) draft about reducing the guide (the 3rd edition) of cholesterol control CHD.Patient surveys the one that blood fat meets following situation and can make a definite diagnosis: (1) cholesterol (TC) >=1.7mmol/L; Low density lipoprotein, LDL (LDL-C) >=3.6mmol/L; High density lipoprotein (HDL-C)≤1.0mmol/L.

The selector 40 routine hyperlipidemia patients of the standard of stating that close, male 20 examples, female's 20 examples, the mean age is 52 years old.

With the powder making in embodiment 1, treat, wherein one day 1 time, each oral one bag, treating 30 days is a course for the treatment of, treats continuously 2 courses for the treatment of.

Criterion of therapeutical effect

With reference to the guideline of clinical investigations > > of the upper treatment of < < new Chinese medicine check hyperlipemia (Zheng Xiao cornel. study of tcm new drug clinical guidance principle [S]. Beijing: Chinese Medicine science and technology publishing house, 2002:85) draft.Cure: after treatment, lipids detection recovers normal; Effective; After treatment, lipids detection reaches following any 1 person, and TC declines >=20%, or TG decline >=40%, or HDL-C rising >=0.26mmol/L, or HDL-C/LDL-C >=20%; Effective: after treatment, lipids detection reaches following any 1 person, be TC decline <20%, or TG decline >=20%<40%, HDL-C rising >=0.104mmol/L<0.26mmol/L, or HDL-C/LDL-C >=10%<20%; Invalid: after treatment, lipids detection is not improved or improves and do not reach effective standard person.

Through treatment, check patient's blood fat, find all patients' cholesterol (TC) <1.5mmol/L; Low density lipoprotein, LDL (LDL-C) <3.5mmol/L; High density lipoprotein (HDL-C) is 1.2-2.0mmol/L, all meets normal blood lipids index clinically.Therefore visible, all patients all meet the standard of healing.

Patient is at treatment front and back equal promoting the circulation of blood, routine urinalysis and draw the inspection of kidney merit, and after medication, every inspection is showed no obvious abnormalities, and patient does not also tell special discomfort.

Claims

1. in a check, treat the medicament of hyperlipemia, it is characterized in that, it is to be made by weight by following bulk drugs: 2 parts of 6 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts of Rhizoma Arisaematis, 5 parts of Herba Lepisori Thunbergiani, 3 parts of Radix Codonopsis, 5 parts of Fructus Pistaciae Veraies, 6 parts, Poria, 3 parts of the Radix Aucklandiae, 2 parts of CUIYUNCAO, 3 parts of water Semen Sojae Preparatums, 9 parts of Fructus Lycii, 2 parts of native broken benefits, 2 parts of Dendrobium jenkinsii Wall ex Lindl．, 5 parts of Fructus Corni, 2 parts of Radix et Rhizoma Smilacis Ripariae and Herba Adenostemmatiss.

2. in check according to claim 1, treat the medicament of hyperlipemia, it is characterized in that, described medicament is tablet, dispersible tablet, instant, powder or granule.